Mastruzzo Claudio, Greco Lucia Roberta, Nakano Koichi, Nakano Atsuko, Palermo Filippo, Pistorio Maria Provvidenza, Salinaro Elisa Trovato, Jordana Manel, Dolovich Jerry, Crimi Dagger Nunzio, Vancheri Carlo
Department of Internal and Specialistic Medicine, Section of Respiratory Diseases and Section of Infectious Diseases, University of Catania, Catania, Italy.
J Allergy Clin Immunol. 2003 Jul;112(1):37-44. doi: 10.1067/mai.2003.1586.
Histologic and immunohistologic features of nasal polyps (NP) are similar to those observed in asthma, thus suggesting a similar immunopathology.
The primary objective of this study was to further understand the anti-inflammatory and immunoregulatory effects of locally delivered corticosteroids. To this end, the effect of intranasal budesonide on the expression of specific cytokines, lymphocyte subsets, and epithelial remodeling in this model of airway tissue inflammation were studied.
We used immunohistochemical techniques to examine nasal mucosae (NM) from healthy individuals and nasal polyp (NP) tissues from patients with nasal polyposis obtained before and after intranasal budesonide treatment.
First, the density of CD8(+) cells was markedly increased in NP tissues after intranasal budesonide treatment from 16.1 +/- 8.4 (M +/- SEM) per mm(2) to 39.9 +/- 24.1. Second, the density of cells immunoreactive for IL-4, IL-5, IFN-gamma, IL-12, and TGF-beta in NP was significantly greater than in control NM tissues. The density of IL-4(+) and IL-5(+) cells in NP tissues significantly decreased after budesonide treatment from 40 +/- 12 to 17.8 +/- 8 and from 19.3 +/- 11 to 10.4 +/- 7, respectively. In contrast, the density of IFN-gamma(+) and IL-12(+) cells remained unchanged. In addition, we found that the density of TGF-beta(+) cells significantly increased after intranasal budesonide from 18 +/- 5 to 41 +/- 9. Third, damage to the entire length of the NP epithelium was quantified using a grading system. The epithelium of untreated NP was substantially damaged; remarkable epithelial restitution with no apparent changes in stromal collagen deposition was observed after intranasal budesonide treatment.
These findings demonstrate that intranasal budesonide induced an increase in CD8 population and a selective regulatory effect on tissue cytokine expression. Furthermore, intranasal budesonide promoted epithelial remodeling. We hypothesize that these immunoregulatory and remodeling effects elicited by steroids might be, at least in part, mediated by the induction of TGF-beta.
鼻息肉(NP)的组织学和免疫组织学特征与哮喘中观察到的特征相似,因此提示存在相似的免疫病理学。
本研究的主要目的是进一步了解局部应用皮质类固醇的抗炎和免疫调节作用。为此,研究了鼻内布地奈德对该气道组织炎症模型中特定细胞因子表达、淋巴细胞亚群和上皮重塑的影响。
我们使用免疫组织化学技术检查了健康个体的鼻黏膜(NM)以及鼻息肉病患者在鼻内布地奈德治疗前后获得的鼻息肉(NP)组织。
首先,鼻内布地奈德治疗后,NP组织中CD8(+)细胞密度显著增加,从每平方毫米16.1±8.4(平均值±标准误)增至39.9±24.1。其次,NP中对IL-4、IL-5、IFN-γ、IL-12和TGF-β呈免疫反应性的细胞密度显著高于对照NM组织。布地奈德治疗后,NP组织中IL-4(+)和IL-5(+)细胞密度分别从40±12显著降至17.8±8以及从19.3±11降至10.4±7。相比之下,IFN-γ(+)和IL-12(+)细胞密度保持不变。此外,我们发现鼻内布地奈德治疗后TGF-β(+)细胞密度从18±5显著增至41±9。第三,使用分级系统对NP上皮全长的损伤进行量化。未经治疗的NP上皮严重受损;鼻内布地奈德治疗后观察到明显的上皮修复,基质胶原沉积无明显变化。
这些发现表明,鼻内布地奈德可诱导CD8细胞数量增加,并对组织细胞因子表达产生选择性调节作用。此外,鼻内布地奈德促进上皮重塑。我们推测,类固醇引发的这些免疫调节和重塑作用可能至少部分是由TGF-β的诱导介导的。